A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer

Clinical Trial ID NCT01021059

PubWeight™ 28.74^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01021059

Top papers